Asclepius Life Sciences Fund

New York, United States Founded: 2016 • Age: 10 yrs
Private equity investments are targeted at healthcare and biotech firms.

About Asclepius Life Sciences Fund

The Asclepius Life Sciences Fund was established in 2016 in New York, United States. Investments are directed toward private equity opportunities in healthcare, pharmaceuticals, personal care, biosciences, and biotechnology sectors. Operations involve funding and supporting companies within these areas, with management handled by principals and directors experienced in life sciences. Geographic focus remains primarily on U.S.-based entities.

  • Headquarter New York, United States
  • Founders Steven Gerst, Steve Glover
  • Sectors
    Financial Services
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Asclepius Life Sciences Fund, L.P.
Operational Areas
Financial Services → Private Capital & Alternative Investments
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Asclepius Life Sciences Fund

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2022 Amount Seed - Asclepius Life Sciences Fund Valuation KKR
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Asclepius Life Sciences Fund

Asclepius Life Sciences Fund has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include KKR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Multiple sectors are invested in by this private equity firm.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Asclepius Life Sciences Fund

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Asclepius Life Sciences Fund

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Asclepius Life Sciences Fund Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Asclepius Life Sciences Fund

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Asclepius Life Sciences Fund

Frequently Asked Questions about Asclepius Life Sciences Fund

When was Asclepius Life Sciences Fund founded?

Asclepius Life Sciences Fund was founded in 2016 and raised its 1st funding round 6 years after it was founded.

Where is Asclepius Life Sciences Fund located?

Asclepius Life Sciences Fund is headquartered in New York, United States. It is registered at New York, New York, United States.

What does Asclepius Life Sciences Fund do?

The Asclepius Life Sciences Fund was established in 2016 in New York, United States. Investments are directed toward private equity opportunities in healthcare, pharmaceuticals, personal care, biosciences, and biotechnology sectors. Operations involve funding and supporting companies within these areas, with management handled by principals and directors experienced in life sciences. Geographic focus remains primarily on U.S.-based entities.

Who are Asclepius Life Sciences Fund's investors?

Asclepius Life Sciences Fund has 1 investor. Key investors include KKR.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available